These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors. Song S; Kong X; Borlongan C; Sava V; Sanchez-Ramos J Cannabis Cannabinoid Res; 2021; 6(1):48-57. PubMed ID: 33614952 [No Abstract] [Full Text] [Related]
31. Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. Kohnz RA; Nomura DK Chem Soc Rev; 2014 Oct; 43(19):6859-69. PubMed ID: 24676249 [TBL] [Abstract][Full Text] [Related]
32. Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists. Pascual AC; Martín-Moreno AM; Giusto NM; de Ceballos ML; Pasquaré SJ Exp Gerontol; 2014 Dec; 60():92-9. PubMed ID: 25456842 [TBL] [Abstract][Full Text] [Related]
33. Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes. Belluomo I; Matias I; Pernègre C; Marsicano G; Chaouloff F J Neurochem; 2015 Apr; 133(1):26-37. PubMed ID: 25626460 [TBL] [Abstract][Full Text] [Related]
34. Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Sugiura T Biofactors; 2009; 35(1):88-97. PubMed ID: 19319851 [TBL] [Abstract][Full Text] [Related]
35. Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures. Sugaya Y; Yamazaki M; Uchigashima M; Kobayashi K; Watanabe M; Sakimura K; Kano M Cell Rep; 2016 Aug; 16(5):1405-1415. PubMed ID: 27452464 [TBL] [Abstract][Full Text] [Related]
36. Cocaine self-administration differentially modulates the expression of endogenous cannabinoid system-related proteins in the hippocampus of Lewis vs. Fischer 344 rats. Rivera P; Miguéns M; Coria SM; Rubio L; Higuera-Matas A; Bermúdez-Silva FJ; de Fonseca FR; Suárez J; Ambrosio E Int J Neuropsychopharmacol; 2013 Jul; 16(6):1277-93. PubMed ID: 23217608 [TBL] [Abstract][Full Text] [Related]
38. Inhibitors of monoacylglycerol lipase as novel analgesics. Hohmann AG Br J Pharmacol; 2007 Mar; 150(6):673-5. PubMed ID: 17293886 [TBL] [Abstract][Full Text] [Related]
39. An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction. Hutch CR; Hillard CJ; Jia C; Hegg CC Neuroscience; 2015 Aug; 300():539-53. PubMed ID: 26037800 [TBL] [Abstract][Full Text] [Related]
40. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination. Manterola A; Bernal-Chico A; Cipriani R; Canedo-Antelo M; Moreno-García Á; Martín-Fontecha M; Pérez-Cerdá F; Sánchez-Gómez MV; Ortega-Gutiérrez S; Brown JM; Hsu KL; Cravatt B; Matute C; Mato S Biochem Pharmacol; 2018 Nov; 157():189-201. PubMed ID: 30075103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]